Suisbact is a dual vaccine designed to help protect pigs against two important bacterial diseases: Glässer’s disease and Streptococcus suis infection. It supports herd health, helps minimize disease-related losses, and contributes to improved productivity and sustainable pig farming.
Suisbact is a dual vaccine designed to help protect pigs against two important bacterial diseases: Glässer’s disease and Streptococcus suis infection. It supports herd health, helps minimize disease-related losses, and contributes to improved productivity and sustainable pig farming.
Streptococcus suis: Serotype 2.
Glaesserella parasuis: Serotype 4.
Suisbact is intended to help prevent:
Glässer’s disease caused by Glaesserella parasuis.
Disease caused by Streptococcus suis.
It also helps reduce disease incidence, mortality, and economic losses in pig production.
Supports herd health and helps reduce reliance on antibiotics as part of an integrated disease-control program.
Dual protection
Targets two important bacterial diseases that can cause outbreaks and significant losses in pig herds.
Support against Glässer’s disease
Designed to help protect pigs against important disease-causing strains of Haemophilus (Glaesserella) parasuis.
Potential cross-protection
The vaccine contains serotype 4 and may provide cross-protection against other important G. parasuis serotypes, including serotypes 5, 13, and 14, according to the manufacturer's data.
Improved production efficiency
Helps reduce treatment costs and production losses, supporting overall farm profitability.
Dosage: 2 ml per dose.
Vaccination program: 2 doses per animal.
Route of administration: Deep intramuscular injection.
First dose: At 7–14 days of age.
Second dose: At 24–28 days of age.
First dose: 8 weeks before introduction into the herd.
Second dose: 11 weeks before introduction into the herd.
First dose: 6 weeks before farrowing.
Second dose: 2 weeks before farrowing.
50-dose vial.
